Moderna, Inc.
(MRNA - NASDAQ)
48,83 USD
📋 Profilo Aziendale

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally.

|